Gilead to Buy Kite Pharma for Roughly $11 Billion

Gilead Sciences has agreed to pay about $11 billion for Kite Pharma and its promising new technology for harnessing the body’s immune system to fight cancer.

from WSJ.com: US Business http://ift.tt/2waUMbY
via IFTTT